Literature DB >> 7560279

Development of muscarinic receptor subtypes in the forebrain of the mouse.

C F Hohmann1, E D Potter, A I Levey.   

Abstract

Cholinergic mechanisms are involved in the regulation of developmental events in the nervous system. Muscarinic cholinergic receptors are thought to be the predominant mediator of cholinergic neurotransmission in the forebrain; however, their developmental role is less well understood. The present study takes advantage of subtype-specific antibodies to muscarinic receptor proteins to investigate the cellular localization of the subtypes in developing mouse forebrain. Receptor protein expression was assessed between postnatal day (PND) 5 and adulthood by immunocytochemical methods with antibodies to m1, m2, and m4 receptors, the most abundant subtypes in rodent brain. We have found dramatic developmental changes in the distribution of all three receptors. In the adult mouse, m1 and m2 receptor immunoreactivity displayed complementary staining patterns in most forebrain areas with m4 sharing similarities in pattern with both m1 and m2. Furthermore, each receptor was expressed transiently in gray matter areas or fiber bundles at various developmental stages. The m4 receptor was also expressed in developing blood vessels. Such transient immunoreactivity was usually associated with times and areas of dynamic morphogenesis, thus suggesting distinct roles for the receptor subtypes in ontogenetic events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560279     DOI: 10.1002/cne.903580106

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  Expression and localization of muscarinic receptors in P19-derived neurons.

Authors:  D Parnas; E Heldman; L Branski; N Feinstein; M Linial
Journal:  J Mol Neurosci       Date:  1998-02       Impact factor: 3.444

2.  Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems.

Authors:  Ingrid Furlan; Rosely Oliveira Godinho
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  On functions of cholinesterases during embryonic development.

Authors:  Laura E Paraoanu; Gunnar Steinert; Janine Klaczinski; Michaela Becker-Röck; Afrim Bytyqi; Paul G Layer
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  M1 muscarinic receptor for the development of auditory cortical function.

Authors:  Karalee K Shideler; Jun Yan
Journal:  Mol Brain       Date:  2010-10-22       Impact factor: 4.041

Review 5.  M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Authors:  Shangtong Jiang; Yanfang Li; Cuilin Zhang; Yingjun Zhao; Guojun Bu; Huaxi Xu; Yun-Wu Zhang
Journal:  Neurosci Bull       Date:  2014-03-03       Impact factor: 5.203

6.  Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex.

Authors:  Valentina Di Liberto; Monica Frinchi; Vincenzo Verdi; Angela Vitale; Fulvio Plescia; Carla Cannizzaro; Maria F Massenti; Natale Belluardo; Giuseppa Mudò
Journal:  Psychopharmacology (Berl)       Date:  2016-12-12       Impact factor: 4.530

Review 7.  Morphogenetic roles of acetylcholine.

Authors:  J M Lauder; U B Schambra
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

8.  Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus.

Authors:  Monica Frinchi; Domenico Nuzzo; Pietro Scaduto; Marta Di Carlo; Maria F Massenti; Natale Belluardo; Giuseppa Mudò
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

9.  Chemogenetic Silencing of Differentiating Cortical Neurons Impairs Dendritic and Axonal Growth.

Authors:  Ina Gasterstädt; Max Schröder; Lukas Cronin; Julian Kusch; Lisa-Marie Rennau; Brix Mücher; Stefan Herlitze; Alexander Jack; Petra Wahle
Journal:  Front Cell Neurosci       Date:  2022-07-15       Impact factor: 6.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.